Newsroom

Advanced care planning for children with serious rare diseases works best when caregivers' needs are addressed as part of the process

A multi-institutional team led by research faculty at Children’s National in Washington, D.C., finds that extracellular vesicles derived from kids’ fat can play a pivotal role in ratcheting up risk for atherosclerotic cardiovascular disease well before any worrisome symptoms become visible.

This year’s symposium will explore the pediatric device clinical trial process, including progress insights, current challenges and potential solutions.

Lower firearm-related deaths among children and adolescents in states with stricter firearm laws.

In late May 2019, Children’s National neonatal intensive care unit (NICU) introduced NicView^TM, a camera system that enables parents to log in from any internet-enabled device to see their infants virtually when they are unable to visit the NICU in person.

Children’s National Health System now offers the PLAT-05 trial for pediatric patients with relapsed positive acute lymphoblastic leukemia (ALL).

Children’s National and The HSC Health Care System have signed a definitive agreement to create an integrated partnership that will provide seamless care for children and young adults with complex medical needs.

A pre-clinical study at Children’s National Health System that investigates the use of nicotine-like, anti-inflammatory medications to reduce limb damage caused by the body’s inflammatory mechanisms has earned the Angela S.M. Kuo Memorial Award Research Grant.